BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12573798)

  • 21. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution and effects of pituitary adenylate cyclase activating peptide in cat and human lower oesophageal sphincter.
    Ny L; Larsson B; Alm P; Ekström P; Fahrenkrug J; Hannibal J; Andersson KE
    Br J Pharmacol; 1995 Dec; 116(7):2873-80. PubMed ID: 8680719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of PACAP receptors and signaling pathways in rabbit gastric muscle cells.
    Murthy KS; Jin JG; Grider JR; Makhlouf GM
    Am J Physiol; 1997 Jun; 272(6 Pt 1):G1391-9. PubMed ID: 9227474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Action of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on the rat vascular system: effects on blood pressure and receptor binding.
    Nandha KA; Benito-Orfila MA; Smith DM; Ghatei MA; Bloom SR
    J Endocrinol; 1991 Apr; 129(1):69-73. PubMed ID: 2030331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
    Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M
    Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive intestinal polypeptide- and pituitary adenylate cyclase activating polypeptide-mediated control of catecholamine release from chromaffin tissue in the rainbow trout, Oncorhynchus mykiss.
    Montpetit CJ; Perry SF
    J Endocrinol; 2000 Sep; 166(3):705-14. PubMed ID: 10974664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
    J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Action of pituitary adenylate cyclase-activating polypeptide on ion transport in guinea pig distal colon.
    Kuwahara A; Kuwahara Y; Mochizuki T; Yanaihara N
    Am J Physiol; 1993 Mar; 264(3 Pt 1):G433-41. PubMed ID: 8384795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits.
    Pedersen NG; Pedersen SH; Dalsgaard T; Lund CO; Nilas L; Ottesen B
    Maturitas; 2004 Dec; 49(4):304-14. PubMed ID: 15531126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological characterization and expression of VIP and PACAP receptors in isolated cranial arteries of the rat.
    Baun M; Hay-Schmidt A; Edvinsson L; Olesen J; Jansen-Olesen I
    Eur J Pharmacol; 2011 Nov; 670(1):186-94. PubMed ID: 21914446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pituitary adenylate cyclase activating polypeptide (PACAP): occurrence and vasodilatory effect in the human uteroplacental unit.
    Steenstrup BR; Jørgensen JC; Alm P; Hannibal J; Junge J; Fahrenkrug J; Ottesen B
    Regul Pept; 1996 Mar; 61(3):197-204. PubMed ID: 8701036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of PACAP (pituitary adenylate cyclase-activating polypeptide)-like and helospectin-like peptides in the teleost gut.
    Olsson C; Holmgren S
    Cell Tissue Res; 1994 Sep; 277(3):539-47. PubMed ID: 7954690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) activate protein kinase C in chick cerebral cortex.
    Nowak JZ; Dejda A; Zawilska JB
    Pol J Pharmacol; 2001; 53(6):695-9. PubMed ID: 11985349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase.
    Nilsson SF; De Neef P; Robberecht P; Christophe J
    Exp Eye Res; 1994 Apr; 58(4):459-67. PubMed ID: 7925682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus.
    Matsuda K; Maruyama K; Nakamachi T; Miura T; Uchiyama M; Shioda S
    Peptides; 2005 Sep; 26(9):1611-6. PubMed ID: 16112400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain.
    Köves K; Arimura A; Görcs TG; Somogyvári-Vigh A
    Neuroendocrinology; 1991 Aug; 54(2):159-69. PubMed ID: 1766552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct receptors mediate pituitary adenylate cyclase-activating peptide- and vasoactive intestinal peptide-induced relaxation of rat ileal longitudinal muscle.
    Ekblad E; Sundler F
    Eur J Pharmacol; 1997 Sep; 334(1):61-6. PubMed ID: 9346329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.